NCT03891134 is a NA clinical trial of Branched Chain Amino Acid in Sarcopenia, sponsored by Chimei Medical Center.

Who is sponsoring NCT03891134?

NCT03891134 is sponsored by Chimei Medical Center.

What drugs are being tested in NCT03891134?

Interventions in NCT03891134: Branched Chain Amino Acid.

What condition does NCT03891134 study?

NCT03891134 studies Sarcopenia.

Is NCT03891134 still recruiting?

NCT03891134 is currently completed. Last updated 26 March 2019.

Last reviewed 2019-03-26 · How we verify

NCT03891134

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nutritional Intervention for Sarcopenia

Completed NA Last updated 26 March 2019

What this trial tests

NA trial testing Branched Chain Amino Acid in Sarcopenia in 630 participants. Completed in 8 June 2017.

Timeline

12 December 2016

Primary endpoint
6 February 2017

8 June 2017

Quick facts

Lead sponsor	Chimei Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	630
Start date	12 December 2016
Primary completion	6 February 2017
Estimated completion	8 June 2017

Drugs / interventions tested

Branched Chain Amino Acid — full drug profile →

Conditions studied

Sarcopenia — all drugs for Sarcopenia →

Sponsor

Chimei Medical Center

Who can join

40 and older, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sarcopenia is an age-related poor healthy outcome. nutrition intervention is one , progressive, generalized loss of muscle mass and the decrement in physical activity. Sarcopenia is associated with subsequent health hazards such as disability, falls, functional degeneration, hospitalization and death. There are similar causes between sarcopenia and constipation such as aging, reduced mobility, changes in diet and co-morbidities. Nutrition plays an important role for muscle maintenance. The trial tries to figure out the effect of enriched branched-chain amino acid (BCAA) nutrient on muscle mass, strength and physical performance of sarcopenia in the middle-aged and old people.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effects of enriched branched-chain amino acid supplementation on sarcopenia.
Ko CH, Wu SJ, Wang ST, Chang YF, et al · · 2020 · cited 46× · PMID 32712600 · DOI 10.18632/aging.103576
Changes of sarcopenia case finding by different Asian Working Group for Sarcopenia in community indwelling middle-aged and old people.
Ko CH, Chuang HY, Wu SJ, Yu SC, et al · · 2022 · cited 10× · PMID 36425107 · DOI 10.3389/fmed.2022.1041186

Verify or expand the search:

Other trials of Branched Chain Amino Acid

Trials testing the same drug.

NCT04246918 — Effect of BCAA Supplementation on Muscle Mass, Muscle Quality and Molecular Markers of Muscle Regeneration in CLD Patien · NA · completed

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other Chimei Medical Center trials

Trials by the same sponsor.

NCT06666361 — Middle-aged and Older Adults with Hypertension in Rural Communities · NA · recruiting
NCT06447441 — Clinical Outcomes Of Mega-dosage Supplementations Of Cholecalciferol In Critically Ill Patients With Sepsis · NA · not yet recruiting
NCT05493774 — Preliminary Exploration of Applying Multi-person Simulation Training to Improve Nurse-led Burn and Scald Nursing Care · NA · completed
NCT06907004 — Developing a Exercise Program for Patients Undergoing Hematopoietic Stem Cell Transplantation · completed
NCT06429020 — Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03891134 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chimei Medical Center
Last refreshed: 26 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03891134.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing